Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The egress of α-synuclein in neuronally derived exosomes predates the clinical presentation of Parkinson's disease (PD), offering a means of developing a predictive or prognostic test. Here, we report the reagentless impedimetric assay of two internal exosome markers (α-synuclein and syntenin-1) from neuronal exosomes. Exosomes were efficiently extracted from patient sera using anti-L1CAM conjugated zwitterionic polymer-modified magnetic beads prior to lysis and analyzed by electrochemical impedance spectroscopy. The quantification of α-synuclein level across 40 clinical samples resolved statistically significant differences between PD patients and healthy controls (HC).

Original publication

DOI

10.1021/acs.analchem.0c03092

Type

Journal article

Journal

Anal Chem

Publication Date

20/10/2020

Volume

92

Pages

13647 - 13651

Keywords

Antibodies, Immobilized, Biomarkers, Dielectric Spectroscopy, Exosomes, Humans, Limit of Detection, Magnetics, Neural Cell Adhesion Molecule L1, Parkinson Disease, Polymers, Syntenins, alpha-Synuclein